Abstract
Objective
To determine the association of Borrelia burgdorferi infection with Alzheimer’s disease or mild cognitive impairment (MCI) in older adults.
Methods
Case–control study. Patients older than 60 years, both sexes, were included. Three groups were created: with probable Alzheimer’s disease cases with NINCDS–ADRDA criteria, MCI cases in those not meeting NINCDS–ADRDA criteria for dementia, but who had an abnormal cognitive evaluation and independence in instrumental activities of daily living (IADL), cognitively healthy controls were diagnosed with normal cognitive evaluation and independence in IADL were identified in the community. Western blot IgG against B. burgdorferi in serum was done in all the participants. Non-conditional logistic regression was applied to estimate the association of Alzheimer’s disease or MCI and seropositive to B. burgdorferi.
Results
Thirty-eight patients with Alzheimer’s disease, mean age of 75.6 ± 3.4 years, 69% were females, education 8.3 ± 4.8 years. 39 patients with MCI, mean age of 72.2 ± 6.8 years, 85% were females, education 11.2 ± 4.2 years. A total of 11/38 (29%) were positive to B. burgdorferi with Alzheimer’s disease, 9/39 (23%) with MCI, and 11/108 (10%) of controls. In patients with Alzheimer’s disease, an adjusted odds ratio (aOR) = 3.65 (95% CI 1.2–11.1) adjusted for education and a history of cerebrovascular disease (CVD) was estimated, and in patients with MCI an aOR = 3.2 (95% CI 1.1–9.1) for a history of diabetes mellitus and CVD was estimated.
Conclusions
In our study, there was an increased risk of Alzheimer’s disease and MCI in seropositive IgG patients to B. burgdorferi.
Key Summary Points
Establish if Borrelia burgdorferi infection is associated with Alzheimer's disease and/or mild cognitive impairment (MCI) in older adults.
AbstractSection FindingsIn patients with Borrelia burgdorferi infection and Alzheimer's disease, an adjusted Odds Ratio (AOR) = 3.65 (95% CI = 1.2−11.1) was estimated, which was similar to that of patients with Borrelia burgdorferi infection and MCI with an AOR = 3.2 (95% CI = 1.1−9.1).
AbstractSection MessageIn our study, there was an increased risk of Alzheimer's disease and MCI in seropositive IgG patients to B. burgdorferi.
Similar content being viewed by others
References
Salloway S, Correia S (2009) Alzheimer disease: time to improve its diagnosis and treatment. Cleve Clin J Med 76(1):49–58. https://doi.org/10.3949/ccjm.76a.072178
Shima K, Kuhlenbaumer G, Rupp J (2010) Chlamydia pneumoniae infection and Alzheimer’s disease: a connection to remember? Med Microbiol Immunol 199(4):283–289. https://doi.org/10.1007/s00430-010-0162-1
Maheshwari P, Eslick GD (2015) Bacterial infection and Alzheimer’s disease: a meta-analysis. J Alzheimers Dis 43(3):957–966. https://doi.org/10.3233/JAD-140621
Mawanda F, Wallace R (2013) Can infections cause Alzheimer’s disease? Epidemiol Rev 35:161–180. https://doi.org/10.1093/epirev/mxs007
Miklossy J (2011) Alzheimer’s disease—a neurospirochetosis. Analysis of the evidence following Koch’s and Hill’s criteria. J Neuroinflamm 8:90. https://doi.org/10.1186/1742-2094-8-90
Noguchi H, Moore JW (1913) A demonstration of treponema pallidum in the brain in cases of general paralysis. J Exp Med 17(2):232–238
Adams JU (2017) Brain infection and alzheimer’s disease pathology. The Scientist. Available from: https://www.the-scientist.com/articles.view/articleNo/50212/title/Infographic--Brain-Infection-and-Alzheimer-s-Disease-Pathology/
MacDonald AB, Miranda JM (1987) Concurrent neocortical borreliosis and Alzheimer’s disease. Hum Pathol 18(7):759–761
Riviere GR, Riviere KH, Smith KS (2002) Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer’s disease. Oral Microbiol Immunol 17(2):113–118
Miklossy J (1993) Alzheimer’s disease—a spirochetosis? Neuro Rep 4(7):841–848
Gordillo-Perez G, Torres J, Solorzano-Santos F, Garduno-Bautista V, Tapia-Conyer R, Munoz O (2003) Seroepidemiologic study of Lyme’s borreliosis in Mexico City and the northeast of the Mexican Republic. Salud Publica Mex 45(5):351–355
Gordillo-Pérez G, Solórzano-Santos F, Cervantes-Castillo A, Sánchez-Vaca G, García- Ramírez R, Mederos-Díaz Adriana et al (2019) Lyme Neuroborreliosis is a neglected, but severe and frequent neurological disease in Mexico. Arch Med Res (in press)
Marques AR (2015) Lyme neuroborreliosis. Contin (Minneap Minn). 21(6):1729–1744. https://doi.org/10.1212/con.0000000000000252 (6 neuroinfectious disease)
Koedel U, Pfister HW (2017) Lyme neuroborreliosis. Curr Opin Infect Dis 30(1):101–107. https://doi.org/10.1097/QCO.0000000000000332
Sanchez JL (2015) Clinical manifestations and treatment of Lyme disease. Clin Lab Med 35(4):765–778. https://doi.org/10.1016/j.cll.2015.08.004
Alby K, Capraro GA (2015) Alternatives to serologic testing for diagnosis of lyme disease. Clin Lab Med 35(4):815–825. https://doi.org/10.1016/j.cll.2015.07.005
Bu XL, Yao XQ, Jiao SS, Zeng F, Liu YH, Xiang Y et al (2015) A study on the association between infectious burden and Alzheimer’s disease. Eur J Neurol 22(12):1519–1525. https://doi.org/10.1111/ene.12477
Marquard RPW, Kurz A (2012) Borrelia Burgdorferi: risk factor in Alzheimer’s disease. Eur J Neurol 19:90–457. https://doi.org/10.1111/j.1468-1331.2012.03888.x
Schriefer ME (2015) Lyme disease diagnosis: serology. Clin Lab Med 35(4):797–814. https://doi.org/10.1016/j.cll.2015.08.001
Pearce N (2016) Analysis of matched case–control studies. BMJ 352:i969. https://doi.org/10.1136/bmj.i969
Niu H, Alvarez-Alvarez I, Guillen-Grima F, Aguinaga-Ontoso I (2017) Prevalence and incidence of Alzheimer’s disease in Europe: a meta-analysis. Neurologia 32(8):523–532. https://doi.org/10.1016/j.nrl.2016.02.016
Carone M, Asgharian M, Jewell NP (2014) Estimating the lifetime risk of dementia in the Canadian elderly population using cross-sectional cohort survival data. J Am Stat Assoc 109(505):24–35. https://doi.org/10.1080/01621459.2013.859076
Romero-Martínez M, Shamah-Levy T, Franco-Núñez A, Villalpando S, Cuevas-Nasu L, Gutiérrez JP, Rivera-Dommarco JA (2013) Encuesta Nacional de Salud y Nutrición 2012: diseño y cobertura. Salud Publica Mex 55(suppl 2):S332–S340
Li R, Singh M (2014) Sex differences in cognitive impairment and Alzheimer’s disease. Front Neuroendocrinol 35(3):385–403. https://doi.org/10.1016/j.yfrne.2014.01.002
Kukull WA, Higdon R, Bowen JD, McCormick WC, Teri L, Schellenberg GD et al (2002) Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol 59(11):1737–1746
Garkowski A, Zajkowska J, Zajkowska A, Kulakowska A, Zajkowska O, Kubas B et al (2017) Cerebrovascular manifestations of Lyme neuroborreliosis—a systematic review of published cases. Front Neurol 8:146. https://doi.org/10.3389/fneur.2017.00146
Gordillo-Pérez G, García-Juárez I, Solórzano-Santos F, Corrales-Zúñiga L, Muñoz-Hernández O, Torres-López J (2017) Serological evidence of Borrelia Burgdorferi infection in Mexican patients with facial palsy. Rev Inves Clin 69:1–5
Ciudin A, Espinosa A, Simo-Servat O, Ruiz A, Alegret M, Hernandez C et al (2017) Type 2 diabetes is an independent risk factor for dementia conversion in patients with mild cognitive impairment. J Diabetes Complicat 31(8):1272–1274. https://doi.org/10.1016/j.jdiacomp.2017.04.018
Marfany A, Sierra C, Camafort M, Domenech M, Coca A (2018) High blood pressure, Alzheimer disease and antihypertensive treatment. Panminerva Med 60(1):8–16. https://doi.org/10.23736/s0031-0808.18.03360-8
OECD (2016) OECD reviews of health systems: Mexico 2016. OECD Publishing, Paris
Nucera A, Hachinski V (2017) Cerebrovascular and Alzheimer disease: fellow travelers or partners in crime? J Neurochem. https://doi.org/10.1111/jnc.14283
Teixeira FB, Saito MT, Matheus FC, Prediger RD, Yamada ES, Maia CSF et al (2017) Periodontitis and Alzheimer’s Disease: a possible comorbidity between oral chronic inflammatory condition and neuroinflammation. Front Aging Neurosci 9:327. https://doi.org/10.3389/fnagi.2017.00327
Tonsekar PP, Jiang SS, Yue G (2017) Periodontal disease, tooth loss and dementia: is there a link? A Syst Rev Gerodontol 34(2):151–163. https://doi.org/10.1111/ger.12261
Sapi E, Bastian SL, Mpoy CM, Scott S, Rattelle A, Pabbati N et al (2012) Characterization of biofilm formation by Borrelia burgdorferi in vitro. PLoS One 7(10):e48277. https://doi.org/10.1371/journal.pone.0048277
Acknowledgements
We express our gratitude and acknowledge the important contributions of the participants and staff of the National Institute of Adult Older Persons Cultural Centers.
Funding
This work was supported by the Instituto Mexicano del Seguro Social (FIS/IMSS Prot MD17/1688) and Universidad Nacional Autónoma de Mexico (Support Program for Graduate Studies 2017). The funder did not influence the design, methods, subject recruitment, data collections, analysis or preparation of the paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no financial or any other kind of personal conflicts with this paper.
Ethical approval
The National Committee of Scientific Research approved the study (R-2016-785-074). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Written informed consent was obtained from all participants included in the study. Written informed consent was approved by the National Committee of Scientific Research.
Rights and permissions
About this article
Cite this article
Herrera-Landero, A., Amaya-Sánchez, L.E., d´Hyver de las-Deses, C. et al. Borrelia burgdorferi as a risk factor for Alzheimer’s dementia and mild cognitive impairment. Eur Geriatr Med 10, 493–500 (2019). https://doi.org/10.1007/s41999-018-0153-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s41999-018-0153-0